NOVARTIS AG-SPONSORED ADR (NVS) Fundamental Analysis & Valuation
NYSE:NVS • US66987V1098
Current stock price
146.87 USD
-0.98 (-0.66%)
Last:
This NVS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. NVS Profitability Analysis
1.1 Basic Checks
- In the past year NVS was profitable.
- NVS had a positive operating cash flow in the past year.
- NVS had positive earnings in each of the past 5 years.
- NVS had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- NVS has a better Return On Assets (11.42%) than 92.15% of its industry peers.
- NVS's Return On Equity of 35.14% is amongst the best of the industry. NVS outperforms 95.29% of its industry peers.
- With an excellent Return On Invested Capital value of 17.76%, NVS belongs to the best of the industry, outperforming 94.76% of the companies in the same industry.
- The Average Return On Invested Capital over the past 3 years for NVS is above the industry average of 13.07%.
- The last Return On Invested Capital (17.76%) for NVS is above the 3 year average (17.15%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.42% | ||
| ROE | 35.14% | ||
| ROIC | 17.76% |
ROA(3y)13.05%
ROA(5y)12.66%
ROE(3y)29.75%
ROE(5y)27.29%
ROIC(3y)17.15%
ROIC(5y)14%
1.3 Margins
- NVS has a better Profit Margin (24.06%) than 92.15% of its industry peers.
- NVS's Profit Margin has improved in the last couple of years.
- NVS has a Operating Margin of 31.82%. This is amongst the best in the industry. NVS outperforms 95.29% of its industry peers.
- NVS's Operating Margin has improved in the last couple of years.
- NVS's Gross Margin of 75.41% is amongst the best of the industry. NVS outperforms 82.72% of its industry peers.
- In the last couple of years the Gross Margin of NVS has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 31.82% | ||
| PM (TTM) | 24.06% | ||
| GM | 75.41% |
OM growth 3Y12.14%
OM growth 5Y6.09%
PM growth 3Y15.69%
PM growth 5Y8.94%
GM growth 3Y0.74%
GM growth 5Y1.28%
2. NVS Health Analysis
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so NVS is creating value.
- Compared to 1 year ago, NVS has less shares outstanding
- The number of shares outstanding for NVS has been reduced compared to 5 years ago.
- NVS has a worse debt/assets ratio than last year.
2.2 Solvency
- An Altman-Z score of 3.50 indicates that NVS is not in any danger for bankruptcy at the moment.
- NVS's Altman-Z score of 3.50 is fine compared to the rest of the industry. NVS outperforms 67.54% of its industry peers.
- NVS has a debt to FCF ratio of 2.94. This is a good value and a sign of high solvency as NVS would need 2.94 years to pay back of all of its debts.
- With an excellent Debt to FCF ratio value of 2.94, NVS belongs to the best of the industry, outperforming 91.10% of the companies in the same industry.
- NVS has a Debt/Equity ratio of 1.02. This is a high value indicating a heavy dependency on external financing.
- With a Debt to Equity ratio value of 1.02, NVS is not doing good in the industry: 76.96% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.02 | ||
| Debt/FCF | 2.94 | ||
| Altman-Z | 3.5 |
ROIC/WACC3.76
WACC4.72%
2.3 Liquidity
- A Current Ratio of 0.85 indicates that NVS may have some problems paying its short term obligations.
- With a Current ratio value of 0.85, NVS is not doing good in the industry: 89.53% of the companies in the same industry are doing better.
- NVS has a Quick Ratio of 0.85. This is a bad value and indicates that NVS is not financially healthy enough and could expect problems in meeting its short term obligations.
- NVS has a Quick ratio of 0.65. This is amonst the worse of the industry: NVS underperforms 89.53% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.85 | ||
| Quick Ratio | 0.65 |
3. NVS Growth Analysis
3.1 Past
- The Earnings Per Share has been growing slightly by 4.83% over the past year.
- Measured over the past years, NVS shows a quite strong growth in Earnings Per Share. The EPS has been growing by 9.21% on average per year.
- The Revenue has been growing slightly by 5.77% in the past year.
- The Revenue has been growing slightly by 2.45% on average over the past years.
EPS 1Y (TTM)4.83%
EPS 3Y13.63%
EPS 5Y9.21%
EPS Q2Q%-12.72%
Revenue 1Y (TTM)5.77%
Revenue growth 3Y9.1%
Revenue growth 5Y2.45%
Sales Q2Q%-0.91%
3.2 Future
- Based on estimates for the next years, NVS will show a small growth in Earnings Per Share. The EPS will grow by 7.49% on average per year.
- NVS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.35% yearly.
EPS Next Y-0.14%
EPS Next 2Y4.63%
EPS Next 3Y6.15%
EPS Next 5Y7.49%
Revenue Next Year2.49%
Revenue Next 2Y3.87%
Revenue Next 3Y4.58%
Revenue Next 5Y5.35%
3.3 Evolution
- The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. NVS Valuation Analysis
4.1 Price/Earnings Ratio
- A Price/Earnings ratio of 16.92 indicates a correct valuation of NVS.
- 85.86% of the companies in the same industry are more expensive than NVS, based on the Price/Earnings ratio.
- Compared to an average S&P500 Price/Earnings ratio of 26.77, NVS is valued a bit cheaper.
- NVS is valuated correctly with a Price/Forward Earnings ratio of 14.96.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of NVS indicates a rather cheap valuation: NVS is cheaper than 81.68% of the companies listed in the same industry.
- When comparing the Price/Forward Earnings ratio of NVS to the average of the S&P500 Index (21.75), we can say NVS is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.92 | ||
| Fwd PE | 14.96 |
4.2 Price Multiples
- NVS's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. NVS is cheaper than 82.72% of the companies in the same industry.
- 85.34% of the companies in the same industry are more expensive than NVS, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 17.66 | ||
| EV/EBITDA | 13.89 |
4.3 Compensation for Growth
- The excellent profitability rating of NVS may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)1.84
EPS Next 2Y4.63%
EPS Next 3Y6.15%
5. NVS Dividend Analysis
5.1 Amount
- With a Yearly Dividend Yield of 3.26%, NVS has a reasonable but not impressive dividend return.
- NVS's Dividend Yield is rather good when compared to the industry average which is at 0.73. NVS pays more dividend than 94.76% of the companies in the same industry.
- NVS's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.26% |
5.2 History
- The dividend of NVS has a limited annual growth rate of 5.38%.
- NVS has been paying a dividend for at least 10 years, so it has a reliable track record.
- As NVS did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)5.38%
Div Incr Years6
Div Non Decr Years6
5.3 Sustainability
- NVS pays out 64.15% of its income as dividend. This is not a sustainable payout ratio.
- NVS's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP64.15%
EPS Next 2Y4.63%
EPS Next 3Y6.15%
NVS Fundamentals: All Metrics, Ratios and Statistics
NYSE:NVS (5/1/2026, 2:35:55 PM)
146.87
-0.98 (-0.66%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Industry StrengthN/A
Industry GrowthN/A
Earnings (Last)04-28 2026-04-28/bmo
Earnings (Next)07-21 2026-07-21
Inst Owners43.85%
Inst Owner Change-3.59%
Ins Owners0.03%
Ins Owner ChangeN/A
Market Cap281.81B
Revenue(TTM)56.26B
Net Income(TTM)13.53B
Analysts70.59
Price Target159.48 (8.59%)
Short Float %0.34%
Short Ratio2.74
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.26% |
Yearly Dividend4.02
Dividend Growth(5Y)5.38%
DP64.15%
Div Incr Years6
Div Non Decr Years6
Ex-Date03-11 2026-03-11 (4.740247)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-4.35%
Min EPS beat(2)-8.52%
Max EPS beat(2)-0.17%
EPS beat(4)1
Avg EPS beat(4)-2.55%
Min EPS beat(4)-8.52%
Max EPS beat(4)0.61%
EPS beat(8)5
Avg EPS beat(8)1.19%
EPS beat(12)8
Avg EPS beat(12)1.42%
EPS beat(16)11
Avg EPS beat(16)2.17%
Revenue beat(2)0
Avg Revenue beat(2)-5.35%
Min Revenue beat(2)-5.8%
Max Revenue beat(2)-4.89%
Revenue beat(4)0
Avg Revenue beat(4)-4.09%
Min Revenue beat(4)-5.8%
Max Revenue beat(4)-2.82%
Revenue beat(8)1
Avg Revenue beat(8)-2.35%
Revenue beat(12)3
Avg Revenue beat(12)-1.97%
Revenue beat(16)4
Avg Revenue beat(16)-0.5%
PT rev (1m)4.64%
PT rev (3m)20.87%
EPS NQ rev (1m)1.12%
EPS NQ rev (3m)-4.85%
EPS NY rev (1m)-0.83%
EPS NY rev (3m)-4.4%
Revenue NQ rev (1m)0.69%
Revenue NQ rev (3m)-0.55%
Revenue NY rev (1m)-0.26%
Revenue NY rev (3m)-0.21%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.92 | ||
| Fwd PE | 14.96 | ||
| P/S | 5.01 | ||
| P/FCF | 17.66 | ||
| P/OCF | 14.7 | ||
| P/B | 7.32 | ||
| P/tB | N/A | ||
| EV/EBITDA | 13.89 |
EPS(TTM)8.68
EY5.91%
EPS(NY)9.82
Fwd EY6.68%
FCF(TTM)8.32
FCFY5.66%
OCF(TTM)9.99
OCFY6.8%
SpS29.32
BVpS20.07
TBVpS-14.86
PEG (NY)N/A
PEG (5Y)1.84
Graham Number62.6088 (-57.37%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.42% | ||
| ROE | 35.14% | ||
| ROCE | 20.54% | ||
| ROIC | 17.76% | ||
| ROICexc | 19.28% | ||
| ROICexgc | 116.92% | ||
| OM | 31.82% | ||
| PM (TTM) | 24.06% | ||
| GM | 75.41% | ||
| FCFM | 28.37% |
ROA(3y)13.05%
ROA(5y)12.66%
ROE(3y)29.75%
ROE(5y)27.29%
ROIC(3y)17.15%
ROIC(5y)14%
ROICexc(3y)20.47%
ROICexc(5y)17.14%
ROICexgc(3y)94.66%
ROICexgc(5y)84.88%
ROCE(3y)20.57%
ROCE(5y)16.8%
ROICexgc growth 3Y10.97%
ROICexgc growth 5Y16.26%
ROICexc growth 3Y23.26%
ROICexc growth 5Y13.82%
OM growth 3Y12.14%
OM growth 5Y6.09%
PM growth 3Y15.69%
PM growth 5Y8.94%
GM growth 3Y0.74%
GM growth 5Y1.28%
F-Score5
Asset Turnover0.47
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.02 | ||
| Debt/FCF | 2.94 | ||
| Debt/EBITDA | 1.68 | ||
| Cap/Depr | 59.51% | ||
| Cap/Sales | 5.71% | ||
| Interest Coverage | 18.84 | ||
| Cash Conversion | 82.3% | ||
| Profit Quality | 117.94% | ||
| Current Ratio | 0.85 | ||
| Quick Ratio | 0.65 | ||
| Altman-Z | 3.5 |
F-Score5
WACC4.72%
ROIC/WACC3.76
Cap/Depr(3y)63.14%
Cap/Depr(5y)55.05%
Cap/Sales(3y)6.73%
Cap/Sales(5y)6.62%
Profit Quality(3y)101.15%
Profit Quality(5y)104.02%
High Growth Momentum
Growth
EPS 1Y (TTM)4.83%
EPS 3Y13.63%
EPS 5Y9.21%
EPS Q2Q%-12.72%
EPS Next Y-0.14%
EPS Next 2Y4.63%
EPS Next 3Y6.15%
EPS Next 5Y7.49%
Revenue 1Y (TTM)5.77%
Revenue growth 3Y9.1%
Revenue growth 5Y2.45%
Sales Q2Q%-0.91%
Revenue Next Year2.49%
Revenue Next 2Y3.87%
Revenue Next 3Y4.58%
Revenue Next 5Y5.35%
EBIT growth 1Y3.01%
EBIT growth 3Y22.35%
EBIT growth 5Y8.7%
EBIT Next Year12.61%
EBIT Next 3Y8.86%
EBIT Next 5Y9.84%
FCF growth 1Y54.57%
FCF growth 3Y9.64%
FCF growth 5Y6.62%
OCF growth 1Y39.29%
OCF growth 3Y10.38%
OCF growth 5Y7%
NOVARTIS AG-SPONSORED ADR / NVS Fundamental Analysis FAQ
What is the ChartMill fundamental rating of NOVARTIS AG-SPONSORED ADR (NVS) stock?
ChartMill assigns a fundamental rating of 6 / 10 to NVS.
What is the valuation status for NVS stock?
ChartMill assigns a valuation rating of 6 / 10 to NOVARTIS AG-SPONSORED ADR (NVS). This can be considered as Fairly Valued.
Can you provide the profitability details for NOVARTIS AG-SPONSORED ADR?
NOVARTIS AG-SPONSORED ADR (NVS) has a profitability rating of 9 / 10.
What is the financial health of NOVARTIS AG-SPONSORED ADR (NVS) stock?
The financial health rating of NOVARTIS AG-SPONSORED ADR (NVS) is 5 / 10.
Can you provide the expected EPS growth for NVS stock?
The Earnings per Share (EPS) of NOVARTIS AG-SPONSORED ADR (NVS) is expected to decline by -0.14% in the next year.